Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics

  1. Lipton, A.
  2. Fizazi, K.
  3. Stopeck, A.T.
  4. Henry, D.H.
  5. Smith, M.R.
  6. Shore, N.
  7. Martin, M.
  8. Vadhan-Raj, S.
  9. Brown, J.E.
  10. Richardson, G.E.
  11. Saad, F.
  12. Yardley, D.A.
  13. Zhou, K.
  14. Balakumaran, A.
  15. Braun, A.
Revue:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Année de publication: 2016

Volumen: 53

Pages: 75-83

Type: Article

DOI: 10.1016/J.EJCA.2015.09.011 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus